DxPx EU 2026 Conference Agenda
Day 1: Thursday, February 5thth, 2026
11:00am – 1:00pm
Investors Only Brunch
Meet old friends and make new connections with other institutional investors.
Register here.
Hosted by Osborne Clark
4:00pm – 6:00pm
DxPx Market Pulse: Global Life Science & Biotools Outlook: Market Dynamics, Deals, and Growth Hotspot
Modeled after ADLM’s renowned International Market Briefing, this one-hour session offers a deep dive into global trends shaping diagnostics, life science tools, and biotools. With insights from XXX, XXX, and XXX, participants will gain data-driven perspectives on market growth, competitive dynamics, and investment activity across key regions. Co-hosted by ADLM, this session will serve as a strategic briefing for investors, startups, and corporates navigating the evolving global landscape.
7:00pm – 9:30pm
Growth for Capital Dinner
Tengstraße 6, 80798 München
Hosted by Pillybury Law
Attending PEs:
8:00pm – 11:00pm
Network Reception
Leonardo Royal Munich – Hotel Bar
Join us for cocktails, finger foods and plenty of networking to open the DxPx Conference.
Requires DxPx conference registration and an opening reception ticket which can be purchased here.
Day 2: Friday, February 6th, 2026
Partnering & Exhibition Area
Plenary: Biomarker
Plenary: Helix
8:30am – 9:00am
Keynote
Details coming soon.
9:00am – 10:00am
One-on-One Partnering and Exhibition
10:00am – 11:00am
Diagnostics: Company presentations
10:00am – 10:15am: Elyte – registration required.
10:15am – 10:30am: Available for purchase
10:30am – 10:45am: Available for purchase
10:45am – 11:00am: Available for purchase
Company presentation slots can be purchased here.
Precision Medicine: Company presentations
10:00am – 10:15am: Available for purchase
10:15am – 10:30am: Available for purchase
10:30am – 10:45am: Available for purchase
10:45am – 11:00am: Available for purchase
Company presentation slots can be purchased here.
11:30pm – 12:30pm
Digital Health: Company presentations
11:30am – 11:45am: Macula Vision
11:45am – 12:00pm: Available for purchase
12:00pm – 12:15pm Available for purchase
12:15pm – 12:30pm: Available for purchase
Company presentation slots can be purchased here.
Biotools: Company presentations
11:30am – 11:45am: Available for purchase
11:45am – 12:00pm: Available for purchase
12:00pm – 12:15pm Available for purchase
12:15pm – 12:30pm: Available for purchase
Company presentation slots can be purchased here.
12:30pm – 1:30pm
Lunch
Lobby
1:30pm - 2:30pm
Expert Dialog 3: Scaling Science
Private equity is fueling unprecedented growth in life science tools and biotools. This session gathers leading investors to explore valuation trends, platform strategies, and M&A dynamics shaping the sector. Insights will feed into a DxPx whitepaper, positioning this discussion as a must-read for startups, strategics, and investors.
Speaker: Simon Wolf
Expert Dialog 2: European Sovernity
Geopolitical shifts and supply-chain vulnerabilities have placed healthcare sovereignty at the top of Europe’s agenda. From critical raw materials to diagnostics, vaccines, and AI infrastructure, Europe faces the challenge of reducing dependencies while staying globally competitive. This panel examines the opportunities and trade-offs of European sovereignty, and how policy, innovation, and investment can safeguard access, resilience, and trust in healthcare.
2:30pm – 5:00pm
DxPx Business Plan Competition: Finalist Pitches
42PLUS1 is a global pitch competition specifically for startups in the diagnostics, digital health, precision medicine, and life sciences tools sectors. It provides an opportunity for early and growth-stage companies to submit their business, get feedback, and compete for funding of up to $2 million.
Opening Remarks from 2025 DxPx Pitch Finalist – Oleg Gusyatin
Moderator / Host – Dr. Heiko Visarius
Jurors:
6:30pm – 9:00pm
Sundowner Cocktail Reception & DxPx Pitch Winner Announcement
Food & drinks provided for all participants along with the DxPx Capital Pitch winner announcement.
42PLUS1 is a global pitch competition specifically for startups in the diagnostics, digital health, precision medicine, and life sciences tools sectors. It provides an opportunity for early and growth-stage companies to submit their business, get feedback, and compete for funding of up to $2 million.
Hosted by: Dr. Mirko Stange and Dr. Heiko Visarius
9:00pm
Cash bar available following reception.
Speakers, Moderators, and Jurors
Bernd Goergen
Michele Colouchi
Mirko Stange
Dr. Heiko Visarius
Simon Wolf
Oleg Gusyatin
Food & drinks for all participants. Winner announcement.
Partnering + Panel Discussions
8:00 a.m. – 7:00 p.m.
Investors – Please join us for this special presentation from Macula Vision Systems.
Moderator:
Leonardo Royal Munich – Downstairs – Partnering & exhibition area
Dr. Mirko Stange
Founder of SLS Partners, DxPx & 42PLUS1
Dr. Mirko Stange
Founder of SLS Partners, DxPx & 42PLUS1
9:20 a.m. – 10:00 a.m.
The Importance of Public Funding in a Challenging Environment
This panel discussion will highlight how grant funding can complement private funding and offer additional support during challenging times. EIT Health-supported start-ups will share how they have incorporated grant funding into their journeys and how it has helped them take their solutions to the next stage, beyond grant funding. They will also do a short demo of their solution.
Moderator:
Emily Rose Jordan
Venture Portfolio Manager
Speakers:
Peeter Padrik
CEO and founder
Sergio Occhipinti
Co-CEO
Severin Benizri
CEO
Ralph Steidl
CEO
9:20 a.m. – 10:00 a.m.
The Importance of Public Funding in a Challenging Environment
This panel discussion will highlight how grant funding can complement private funding and offer additional support during challenging times. EIT Health-supported start-ups will share how they have incorporated grant funding into their journeys and how it has helped them take their solutions to the next stage, beyond grant funding. They will also do a short demo of their solution.
Moderator:
Emily Rose Jordan
Venture Portfolio Manager
Speakers:
Peeter Padrik
CEO and founder
Sergio Occhipinti
Co-CEO
Severin Benizri
CEO
Ralph Steidl
CEO
10:20 a.m. – 11:00 a.m.
Panel Discussion: The Power Duo: Family Offices and VC Investments for an Optimized Cap Table
This event will explore the strategic advantages of integrating family offices and venture capital investments to strengthen and diversify your cap table. Expect to gain valuable insights from five distinguished family offices from Europe and the US, as they share their expertise, success stories, and practical advice on leveraging this powerful combination to fuel growth and innovation. Don’t miss this opportunity to learn from leading industry experts and enhance your investment strategy.
Panelists:
Dirk Kreder
Fabian Scheugenpflug
Axel Heinemann
Peer Schatz
Moderator:
Michele Colucci
Founder
11:20 a.m. – 12:00 p.m.
Panel Discussion: Transforming Drug Development: The Strategic Value of Diagnostics in Personalized Medicine
Leading Pharma executives and industry experts will discuss the strategic advantages of incorporating diagnostics early in the development pipeline. Topics will include:
- How companion diagnostics can accelerate drug approvals and improve success rates.
- The role of diagnostics in optimizing patient recruitment and stratification.
- Collaborative models between Pharma, diagnostics companies, and healthcare providers.
- Future trends and innovations driving the next generation of personalized therapies.
Join us for an insightful discussion on harnessing the power of diagnostics to unlock the full potential of personalized medicine and drive the future of healthcare.
Moderator:
Matthias Breugelmans
VP and Global Head of Research and Development
Speakers:
Nachiket Kashikar
CEO and Co-founder
Thomas Di Maio
EU-Canada Diagnostic Lead
Justin Guinney
Senior Vice President
Lee-Anne Zinetti
Executive Director, Healthcare Systems, Partnerships & Diagnostics – Oncology
12:20 p.m. – 12:50 p.m.
Lunch Workshop: Kick-start & accelerate Startup Growth using contextual advertising and marketing tactics based on scientific data
Ready to boost your startup’s growth? Join our lunchtime workshop hosted by PubGrade. Learn how leveraging scientific data and targeting audiences through the research they produced and consume can enhance your marketing strategy.
Philipp, PubGrade’s Co-Founder, will discuss the importance of identifying your product’s unique benefits for a paying audience. He’ll introduce PubGrade’s platform to help engage these specific audiences effectively.
Tim, an expert in life sciences, will share a case study on using these tactics for a successful product launch.
Don’t miss this chance to increase visibility and convert prospects into customers.
With limited spaces available, this presentation requires a separate, free registration.
Dr. Tim Hiddemann is a seasoned expert in the life sciences sector, having co-founded antibodies-online.com, where he successfully integrated technology and customer focus. He currently serves as a board member for Labforward and has recently been appointed as a partner at Peppermint Venture Partners, where he invests in life science research tools and service companies across Europe.
Dr. Philipp Eckerle is a Co-Founder of PubGrade. Over the last decade he has been working with many multinational corporations as well as start-ups supporting their marketing and advertising activities through PubGrade’s platform.
Tim Hiddemann
Partner
Philipp Eckerle
Co-founder
1:00 p.m. – 1:40 p.m.
Advancing Personalized Medicine: Innovations in Diagnostics and Therapeutics
This panel will explore the latest advancements in personalized medicine, focusing on the integration of diagnostics and therapeutics to enhance patient outcomes. Topics will include the development of companion diagnostics, the role of artificial intelligence in patient stratification, and the investment landscape supporting these innovations.
Moderator:
Luc Henry
Founder and CEO
Speakers:
Brian DellaValle
Founder and CEO
Hannah Mamuszka
CEO
Stefanie Wojciech
Innovation Scout
Simon Turner
Partner
Dr. Michael Zaiac
Head of Medical Affairs Oncology
2:00 p.m. – 4:00 p.m.
42PLUS1 Finalist Live Pitch: Where Innovation Meets Opportunity
Join us at the DxPx conference for the highly anticipated 42PLUS1 finalist live pitch, where the most promising startups in diagnostics, digital health, and life science tools compete for substantial funding. This is your chance to witness groundbreaking innovations from seed to Series A stage startups that are transforming the industry.
For those looking to elevate their startup to the next level, 42PLUS1 offers more than just funding. By applying at 42plus1.com, you can gain invaluable feedback from over 50 experienced online jurors—industry leaders who understand the challenges and opportunities in your field.
Don’t miss this opportunity to see the future of healthcare unfold and explore how your startup can be part of it!
Moderator:
Dr. Mirko Stange
Founder of SLS Partners, DxPx & 42PLUS1
Judges:
Dr. Bernd Goergen
Partner
Louise Warme
Head of We Venture Capital
Joey Mason
Co-Founder and Partner
Dave Whelan
Managing Director
Sebastian Swienty
Senior Director, Corporate Business Development Licensing
Craig Cooper
Partner
Finalists:
4:00 p.m. – 4:20 p.m.
The Value of Healthcare Data in Times of AI
This session will dive into how healthcare data, when combined with AI, is poised to reshape the future of medicine, with a focus on data veracity and training large language models (LLMs). As Bill Gates recently noted, “the biggest revolution through AI will be in education and healthcare.” You’ll explore how accurate data fuels AI’s potential for groundbreaking healthcare innovations, how effectiveness gets a boost, how staff shortage will be overcome, and how overall costs will shrink. Whether you’re a family office principal, founder, or VC, this workshop will provide critical insights into the intersection of AI and healthcare data – a space where transformative change is happening right now. Don’t miss this opportunity to learn from industry leaders and capitalize on new growth and impact in this rapidly evolving field.
ACP Healthtech Fund, managed by Aescuvest Capital Partners, is an investment vehicle focused on transformative healthtech innovations. The fund targets high-growth opportunities at the intersection of healthcare and technology, particularly pre-regulatory approval companies poised to make significant strides in personalized diagnostics and preventive care. By strategically investing in companies nearing critical regulatory milestones, ACP ensures both a high potential for financial returns and a meaningful impact on patient outcomes. The fund’s disciplined approach and proven track record of success offer investors a unique chance to capitalize on the next generation of healthcare breakthroughs, delivering substantial value while advancing global healthcare.
Dr. Patrick Pfeffer
Private Wealth Holder, General Partner ACP Healthtech | CEO Aescuvest
Dr. Patrick Pfeffer operates the largest network of family offices investing in healthcare across Europe and Turkey. After ea rning his PhD in machine learning, he had a successful career in pharma, including serving as Managing Director of WebMD’s Medscape platform in Europe, where he was an integral part of preparing the company for its multi-billion-dollar exit to KKR. Today, as the Founder and Managing Partner at ACP Healthtech, he leads efforts to transform healthcare from reactive “sickcare” to proactive solutions.
His strategic vision focuses on healthtech innovations that enhance patient outcomes while offering significant financial returns, creating opportunities for investors to drive impactful growth in the future of healthcare.
Speaker:
Dr. Patrick Pfeffer
Founder & CEO
4:30 p.m. – 5:10 p.m.
Navigating the Wild West: Bridging the Gap for Startups Entering the US Market
Breaking into the US diagnostic market can feel like venturing into uncharted territory for international startups. This panel, featuring DMC, and Mayo Clinic Ventures as two spearhead organizations of the Mayo Clinics ecosystems will share who Mayo can support European startups. Perfect for startups aiming to expand their footprint in the US and scale their innovations globally.
Speaker:
Seth Eisenman
Director of Licensing
Moderators:
Cihat Cenziz
Principal
Kylle Jordan
Business Development Manager
5:20 p.m. – 5:50 p.m.
Bridging Innovation and Clinical Practice: Connecting Startups, Industry, and Clinical Laboratories to Meet Unmet Clinical Needs
The rapid advancement of emerging diagnostic technologies offers significant potential to address critical gaps in clinical care. Translating these innovations into patient outcomes requires cross-disciplinary collaboration. This roundtable, hosted by the IFCC Emerging Technologies Division (ETD), unites diagnostic startups, industry experts, and laboratory medicine specialists to tackle unmet clinical needs.
The session will explore strategies for adopting cutting-edge technologies like artificial intelligence, point-of-care diagnostics, and novel biomarkers. Panelists will address challenges in scaling innovations, the need for clinical validation, and how laboratories can influence development to meet real-world demands. By fostering dialogue, we aim to break silos and create actionable pathways for integrating new diagnostics into patient care.
Speakers:
Prof. Damien Gruson
Cliniques Universitaires Saint-Luc, Brussels Belgium
IFCC Division on Emerging Technologies
Dr. Sven Ebert
Roche Diagnostics
IFCC Division on Emerging Technologies
Moderator:
Dr. Bernard Gouget
National Committee for the Selection of Reference Laboratories, France
IFCC Division on Emerging Technologies
Christoph Brandenberger
Managing Director
5:50 p.m. – 6:00 p.m.
Closing Remarks: Outlook 2025
Christoph Brandenberger
Managing Director
7:00 p.m. – 9:00 p.m.
DxPx After Party: Unwind & Connect
The networking doesn’t have to stop when the conference ends! Join us for the DxPx After-Party, where you can relax, enjoy some drinks, and continue the conversations in a more informal setting. Whether you’re looking to solidify connections made during the day or just unwind with fellow industry professionals, this is the perfect opportunity to keep the momentum going.
Location: DxPx Venue / Hotel Leonardo Royal.
Day 1: Thursday, February 5thth, 2026
7:00pm – 9:30pm
Growth for Capital – Private Event
Bodega Restaurant Munich
Join 20 Private Equity & 20 Growth-stage companies for good food, good wine and good discussion. Join TPG, SHS Capital, EQT, Afinium, Triton, Apposite Capital, BoardOak and more!
Thanks to our co-host KPMG.
Participation is free but application required.
8:00pm – 12:00am
DxPx Opening Reception
Leonardo Royal Munich – Hotel Bar
Falling last years experience, we took wine of the menu and added more cocktails. Finger food available.
Registration via: link.
Day 2: Friday, February 6th, 2026
8:30am – 9:00am
Keynote
Leonardo Royal Munich – Partnering & Exhibition Area
Details coming soon.
9:15am – 10:30am
DxPx Market Pulse: Global Life Science & Biotools Outlook: Market Dynamics, Deals, and Growth Hotspot
Leonardo Royal Munich – Partnering & Exhibition Area
Modeled after ADLM’s renowned International Market Briefing, this one-hour session offers a deep dive into global trends shaping diagnostics, life science tools, and biotools. With insights from XXX, XXX, and XXX, participants will gain data-driven perspectives on market growth, competitive dynamics, and investment activity across key regions. Co-hosted by ADLM, this session will serve as a strategic briefing for investors, startups, and corporates navigating the evolving global landscape.
9:30am – 8:00pm
DxPx Event
Leonardo Royal Munich – Partnering & Exhibition Area
One-on-one partnering and exhibition.
11:00am – 12:00pm
Company presentation track 1: Dx
Room 1
Apply here: link.
11:00am – 12:00pm
Lunch
Leonardo Royal Munich – Downstairs
12:00pm – 1:00pm
Company presentation track 2: Biotools
Room 1
Apply here: link.
1:15pm – 2:15pm
Company presentation track 3: Precision Medicine
Room 1
Apply here: link.
1:15pm – 2:15pm
Company presentation track 4: Digital Health
Room 1
Apply here: link.
11:00am – 12:00pm
Expert Dialog 1: Total Recall – What Would It Take to Build a Functional Healthcare System?
Room 2
Despite unprecedented innovation and record investment, healthcare systems worldwide remain fragmented, inefficient, and unequal. This panel brings together experts from industry, policy, and clinical practice to reimagine healthcare from the ground up. What would it take to create a truly functional, patient-centered system? Join us as we explore systemic redesign, data-driven care, and the role of emerging technologies in building a sustainable future.
1:00pm – 2:00pm
Expert Dialog 2: European Sovereignty – Implications for the Healthcare System
Room 2
Geopolitical shifts and supply-chain vulnerabilities have placed healthcare sovereignty at the top of Europe’s agenda. From critical raw materials to diagnostics, vaccines, and AI infrastructure, Europe faces the challenge of reducing dependencies while staying globally competitive. This panel examines the opportunities and trade-offs of European sovereignty, and how policy, innovation, and investment can safeguard access, resilience, and trust in healthcare.
2:30pm – 3:00pm
Scaling Science: Private Equity’s Playbook for the Next Wave of Life Science Tools Growth
Room 2
Private equity is fueling unprecedented growth in life science tools and biotools. This session gathers leading investors to explore valuation trends, platform strategies, and M&A dynamics shaping the sector. Insights will feed into a DxPx whitepaper, positioning this discussion as a must-read for startups, strategics, and investors.
2:30pm – 3:00pm
DxPx Capital Pitch
Room 2
Top 6 startups pitch for funding – Short blurb
Read interview with our latest winner here.
6:00pm – 8:00pm
DxPx Sundowner Cocktail Reception
Leonardo Royal Munich
Food & drinks for all participants. Winner announcement.
8:00pm
Pay for your selves upstairs.
Day 3: Saturday, February 7th, 2026
10:00am
Investors-only breakfast
Cafe Reitschule Munich
Free but separate registration needed.
Apply here: link.
Food & drinks for all participants. Winner announcement.
Partnering + Panel Discussions
8:00 a.m. – 7:00 p.m.
Investors – Please join us for this special presentation from Macula Vision Systems.
Moderator:
Leonardo Royal Munich – Downstairs – Partnering & exhibition area
Dr. Mirko Stange
Founder of SLS Partners, DxPx & 42PLUS1
Dr. Mirko Stange
Founder of SLS Partners, DxPx & 42PLUS1
9:20 a.m. – 10:00 a.m.
The Importance of Public Funding in a Challenging Environment
This panel discussion will highlight how grant funding can complement private funding and offer additional support during challenging times. EIT Health-supported start-ups will share how they have incorporated grant funding into their journeys and how it has helped them take their solutions to the next stage, beyond grant funding. They will also do a short demo of their solution.
Moderator:
Emily Rose Jordan
Venture Portfolio Manager
Speakers:
Peeter Padrik
CEO and founder
Sergio Occhipinti
Co-CEO
Severin Benizri
CEO
Ralph Steidl
CEO
9:20 a.m. – 10:00 a.m.
The Importance of Public Funding in a Challenging Environment
This panel discussion will highlight how grant funding can complement private funding and offer additional support during challenging times. EIT Health-supported start-ups will share how they have incorporated grant funding into their journeys and how it has helped them take their solutions to the next stage, beyond grant funding. They will also do a short demo of their solution.
Moderator:
Emily Rose Jordan
Venture Portfolio Manager
Speakers:
Peeter Padrik
CEO and founder
Sergio Occhipinti
Co-CEO
Severin Benizri
CEO
Ralph Steidl
CEO
10:20 a.m. – 11:00 a.m.
Panel Discussion: The Power Duo: Family Offices and VC Investments for an Optimized Cap Table
This event will explore the strategic advantages of integrating family offices and venture capital investments to strengthen and diversify your cap table. Expect to gain valuable insights from five distinguished family offices from Europe and the US, as they share their expertise, success stories, and practical advice on leveraging this powerful combination to fuel growth and innovation. Don’t miss this opportunity to learn from leading industry experts and enhance your investment strategy.
Panelists:
Dirk Kreder
Fabian Scheugenpflug
Axel Heinemann
Peer Schatz
Moderator:
Michele Colucci
Founder
11:20 a.m. – 12:00 p.m.
Panel Discussion: Transforming Drug Development: The Strategic Value of Diagnostics in Personalized Medicine
Leading Pharma executives and industry experts will discuss the strategic advantages of incorporating diagnostics early in the development pipeline. Topics will include:
- How companion diagnostics can accelerate drug approvals and improve success rates.
- The role of diagnostics in optimizing patient recruitment and stratification.
- Collaborative models between Pharma, diagnostics companies, and healthcare providers.
- Future trends and innovations driving the next generation of personalized therapies.
Join us for an insightful discussion on harnessing the power of diagnostics to unlock the full potential of personalized medicine and drive the future of healthcare.
Moderator:
Matthias Breugelmans
VP and Global Head of Research and Development
Speakers:
Nachiket Kashikar
CEO and Co-founder
Thomas Di Maio
EU-Canada Diagnostic Lead
Justin Guinney
Senior Vice President
Lee-Anne Zinetti
Executive Director, Healthcare Systems, Partnerships & Diagnostics – Oncology
12:20 p.m. – 12:50 p.m.
Lunch Workshop: Kick-start & accelerate Startup Growth using contextual advertising and marketing tactics based on scientific data
Ready to boost your startup’s growth? Join our lunchtime workshop hosted by PubGrade. Learn how leveraging scientific data and targeting audiences through the research they produced and consume can enhance your marketing strategy.
Philipp, PubGrade’s Co-Founder, will discuss the importance of identifying your product’s unique benefits for a paying audience. He’ll introduce PubGrade’s platform to help engage these specific audiences effectively.
Tim, an expert in life sciences, will share a case study on using these tactics for a successful product launch.
Don’t miss this chance to increase visibility and convert prospects into customers.
With limited spaces available, this presentation requires a separate, free registration.
Dr. Tim Hiddemann is a seasoned expert in the life sciences sector, having co-founded antibodies-online.com, where he successfully integrated technology and customer focus. He currently serves as a board member for Labforward and has recently been appointed as a partner at Peppermint Venture Partners, where he invests in life science research tools and service companies across Europe.
Dr. Philipp Eckerle is a Co-Founder of PubGrade. Over the last decade he has been working with many multinational corporations as well as start-ups supporting their marketing and advertising activities through PubGrade’s platform.
Tim Hiddemann
Partner
Philipp Eckerle
Co-founder
1:00 p.m. – 1:40 p.m.
Advancing Personalized Medicine: Innovations in Diagnostics and Therapeutics
This panel will explore the latest advancements in personalized medicine, focusing on the integration of diagnostics and therapeutics to enhance patient outcomes. Topics will include the development of companion diagnostics, the role of artificial intelligence in patient stratification, and the investment landscape supporting these innovations.
Moderator:
Luc Henry
Founder and CEO
Speakers:
Brian DellaValle
Founder and CEO
Hannah Mamuszka
CEO
Stefanie Wojciech
Innovation Scout
Simon Turner
Partner
Dr. Michael Zaiac
Head of Medical Affairs Oncology
2:00 p.m. – 4:00 p.m.
42PLUS1 Finalist Live Pitch: Where Innovation Meets Opportunity
Join us at the DxPx conference for the highly anticipated 42PLUS1 finalist live pitch, where the most promising startups in diagnostics, digital health, and life science tools compete for substantial funding. This is your chance to witness groundbreaking innovations from seed to Series A stage startups that are transforming the industry.
For those looking to elevate their startup to the next level, 42PLUS1 offers more than just funding. By applying at 42plus1.com, you can gain invaluable feedback from over 50 experienced online jurors—industry leaders who understand the challenges and opportunities in your field.
Don’t miss this opportunity to see the future of healthcare unfold and explore how your startup can be part of it!
Moderator:
Dr. Mirko Stange
Founder of SLS Partners, DxPx & 42PLUS1
Judges:
Dr. Bernd Goergen
Partner
Louise Warme
Head of We Venture Capital
Joey Mason
Co-Founder and Partner
Dave Whelan
Managing Director
Sebastian Swienty
Senior Director, Corporate Business Development Licensing
Craig Cooper
Partner
Finalists:
4:00 p.m. – 4:20 p.m.
The Value of Healthcare Data in Times of AI
This session will dive into how healthcare data, when combined with AI, is poised to reshape the future of medicine, with a focus on data veracity and training large language models (LLMs). As Bill Gates recently noted, “the biggest revolution through AI will be in education and healthcare.” You’ll explore how accurate data fuels AI’s potential for groundbreaking healthcare innovations, how effectiveness gets a boost, how staff shortage will be overcome, and how overall costs will shrink. Whether you’re a family office principal, founder, or VC, this workshop will provide critical insights into the intersection of AI and healthcare data – a space where transformative change is happening right now. Don’t miss this opportunity to learn from industry leaders and capitalize on new growth and impact in this rapidly evolving field.
ACP Healthtech Fund, managed by Aescuvest Capital Partners, is an investment vehicle focused on transformative healthtech innovations. The fund targets high-growth opportunities at the intersection of healthcare and technology, particularly pre-regulatory approval companies poised to make significant strides in personalized diagnostics and preventive care. By strategically investing in companies nearing critical regulatory milestones, ACP ensures both a high potential for financial returns and a meaningful impact on patient outcomes. The fund’s disciplined approach and proven track record of success offer investors a unique chance to capitalize on the next generation of healthcare breakthroughs, delivering substantial value while advancing global healthcare.
Dr. Patrick Pfeffer
Private Wealth Holder, General Partner ACP Healthtech | CEO Aescuvest
Dr. Patrick Pfeffer operates the largest network of family offices investing in healthcare across Europe and Turkey. After ea rning his PhD in machine learning, he had a successful career in pharma, including serving as Managing Director of WebMD’s Medscape platform in Europe, where he was an integral part of preparing the company for its multi-billion-dollar exit to KKR. Today, as the Founder and Managing Partner at ACP Healthtech, he leads efforts to transform healthcare from reactive “sickcare” to proactive solutions.
His strategic vision focuses on healthtech innovations that enhance patient outcomes while offering significant financial returns, creating opportunities for investors to drive impactful growth in the future of healthcare.
Speaker:
Dr. Patrick Pfeffer
Founder & CEO
4:30 p.m. – 5:10 p.m.
Navigating the Wild West: Bridging the Gap for Startups Entering the US Market
Breaking into the US diagnostic market can feel like venturing into uncharted territory for international startups. This panel, featuring DMC, and Mayo Clinic Ventures as two spearhead organizations of the Mayo Clinics ecosystems will share who Mayo can support European startups. Perfect for startups aiming to expand their footprint in the US and scale their innovations globally.
Speaker:
Seth Eisenman
Director of Licensing
Moderators:
Cihat Cenziz
Principal
Kylle Jordan
Business Development Manager
5:20 p.m. – 5:50 p.m.
Bridging Innovation and Clinical Practice: Connecting Startups, Industry, and Clinical Laboratories to Meet Unmet Clinical Needs
The rapid advancement of emerging diagnostic technologies offers significant potential to address critical gaps in clinical care. Translating these innovations into patient outcomes requires cross-disciplinary collaboration. This roundtable, hosted by the IFCC Emerging Technologies Division (ETD), unites diagnostic startups, industry experts, and laboratory medicine specialists to tackle unmet clinical needs.
The session will explore strategies for adopting cutting-edge technologies like artificial intelligence, point-of-care diagnostics, and novel biomarkers. Panelists will address challenges in scaling innovations, the need for clinical validation, and how laboratories can influence development to meet real-world demands. By fostering dialogue, we aim to break silos and create actionable pathways for integrating new diagnostics into patient care.
Speakers:
Prof. Damien Gruson
Cliniques Universitaires Saint-Luc, Brussels Belgium
IFCC Division on Emerging Technologies
Dr. Sven Ebert
Roche Diagnostics
IFCC Division on Emerging Technologies
Moderator:
Dr. Bernard Gouget
National Committee for the Selection of Reference Laboratories, France
IFCC Division on Emerging Technologies
Christoph Brandenberger
Managing Director
5:50 p.m. – 6:00 p.m.
Closing Remarks: Outlook 2025
Christoph Brandenberger
Managing Director
7:00 p.m. – 9:00 p.m.
DxPx After Party: Unwind & Connect
The networking doesn’t have to stop when the conference ends! Join us for the DxPx After-Party, where you can relax, enjoy some drinks, and continue the conversations in a more informal setting. Whether you’re looking to solidify connections made during the day or just unwind with fellow industry professionals, this is the perfect opportunity to keep the momentum going.
Location: DxPx Venue / Hotel Leonardo Royal.
Speakers & Moderators
We look forward to seeing you at DxPx U.S.!
Date & Location:
Reception: Sunday, January 26th, 2025
Partnering Day & 42PLUS1: January 27th, 2025
Leonardo Royal Munich
Moosacher Straße 90 | 80809 München | Germany
